Praxis Precision Medicines, Inc.

NASDAQ:PRAX

40.75 (USD) • At close September 8, 2025
Bedrijfsnaam Praxis Precision Medicines, Inc.
Symbool PRAX
Munteenheid USD
Prijs 40.75
Beurswaarde 857,616,350
Dividendpercentage 0%
52-weken bereik 26.7 - 91.83
Industrie Biotechnology
Sector Healthcare
CEO Mr. Marcio Souza M.B.A.
Website https://www.praxismedicines.com

An error occurred while fetching data.

Over Praxis Precision Medicines, Inc.

Praxis Precision Medicines, Inc., a clinical-stage biopharmaceutical company, develops therapies for central nervous system disorders characterized by neuronal imbalance. Its lead product candidates include PRAX-114, an extrasynaptic-preferring GABAA receptor positive allosteric modulator that is in Phase IIa clinical trial for the treatment of major depressive disorder and perimenopausal depression; and

Vergelijkbare Aandelen

Adicet Bio, Inc. logo

Adicet Bio, Inc.

ACET

0.763 USD

Vaxart, Inc. logo

Vaxart, Inc.

VXRT

0.385 USD

Kinnate Biopharma Inc. logo

Kinnate Biopharma Inc.

KNTE

2.65 USD

Rallybio Corporation logo

Rallybio Corporation

RLYB

0.594 USD

Day One Biopharmaceuticals, Inc. logo

Day One Biopharmaceuticals, Inc.

DAWN

7.47 USD

Alpha Tau Medical Ltd. logo

Alpha Tau Medical Ltd.

DRTS

3.69 USD

IRadimed Corporation logo

IRadimed Corporation

IRMD

71.85 USD

RAPT Therapeutics, Inc. logo

RAPT Therapeutics, Inc.

RAPT

13.28 USD

Nuvalent, Inc. logo

Nuvalent, Inc.

NUVL

79.83 USD

Financiële Gegevens

Cijfers zijn in miljoenen (USD)

Cijfers zijn in miljoenen (USD)